Physician profile
Yitzhak Belsh
NPI 1184824690
$29,363.86
in general payments reported to CMS, 2019-2025
9 companies · $175 in 2025
The $175 reported for 2025 was more than what 78% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $6,866 · 2021: $177 · 2022: $18.92 · 2024: $217 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $27,745.19 | 2019-2021 | |
| Medtronic Vascular, INC. | $1,052.72 | 2020 | |
| Janssen Biotech, INC. | $365.88 | 2024-2025 | Simponi, Simponi Aria, Tremfya |
| Medical Device Business Services, INC. | $84.08 | 2019 | |
| Seapearl East, INC | $42.08 | 2021-2022 | |
| Acelrx Pharmaceuticals, INC. | $34.78 | 2021 | |
| Qol Medical, LLC | $21.08 | 2024 | Sucraid |
| Boston Scientific Corporation | $12.99 | 2020 | |
| Phathom Pharmaceuticals, INC. | $5.06 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yitzhak Belsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.